PolyCrystalLine is a young dynamic company which has established itself as a leader in research and characterization of solid-state compounds, especially in the pharmaceutical sector.
We have developed a university background into a business venture; blending academic know-how with business-like agility and flexibility. By working closely with the academic world, we are able to apply an innovative and avant-garde approach to the solving of scientific, commercial and patenting problems.
Our extensive experience in the characterization of solid-state compounds and the study of polymorphism has led to the development of specific and flexible research protocols. These can be adapted to meet the needs of the pharmaceutical industry.
We are able to satisfy the most varied research needs and budget requirements, ranging from in-depth analysis of APIs and compounds/solvates to quick low-cost screening and studies involving patent issues.